Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Woo-Young | - |
dc.contributor.author | Lee, Ho-Young | - |
dc.date.accessioned | 2022-04-19T10:46:36Z | - |
dc.date.available | 2022-04-19T10:46:36Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.issn | 1742-464X | - |
dc.identifier.issn | 1742-4658 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/148016 | - |
dc.description.abstract | Formation of new blood vessels is required for the growth and metastasis of all solid tumors. New blood vessels are established in tumors mainly through angiogenesis. Brain tumors in particular are highly angiogenic. Therefore, interventions designed to prevent angiogenesis may be effective at controlling brain tumors. Indeed, many recent findings from preclinical and clinical studies of antiangiogenic therapy for brain tumors have shown that it is a promising approach to managing this deadly disease, especially when combined with other cytotoxic treatments. In this minireview, we summarize the basic characteristics of brain tumor angiogenesis and the role of known angiogenic factors in regulating this angiogenesis, which may be targets of antiangiogenic therapy. We also discuss the current status of antiangiogenic therapy for brain tumors, the suggested mechanisms of this therapy and the limitations of this strategy. | - |
dc.format.extent | 12 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY-BLACKWELL PUBLISHING | - |
dc.title | Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/j.1742-4658.2009.07177.x | - |
dc.identifier.scopusid | 2-s2.0-68849084343 | - |
dc.identifier.wosid | 000268791300005 | - |
dc.identifier.bibliographicCitation | FEBS JOURNAL, v.276, no.17, pp 4653 - 4664 | - |
dc.citation.title | FEBS JOURNAL | - |
dc.citation.volume | 276 | - |
dc.citation.number | 17 | - |
dc.citation.startPage | 4653 | - |
dc.citation.endPage | 4664 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | Antiangiogenic therapy | - |
dc.subject.keywordAuthor | Avarstin | - |
dc.subject.keywordAuthor | BBB | - |
dc.subject.keywordAuthor | Brain tumor angiogenesis | - |
dc.subject.keywordAuthor | Clinical trial | - |
dc.subject.keywordAuthor | GBM | - |
dc.subject.keywordAuthor | Resistance | - |
dc.subject.keywordAuthor | VEGF | - |
dc.subject.keywordAuthor | Vessel normalization | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.